Posizolid

Posizolid
Clinical data
Other names	AZD2563
ATC code	none;
Identifiers
	IUPAC name (5R)-3-[4-[1-[(2S)-2,3-Dihydroxypropanoyl]-3,6-dihydro-2H-pyridin-4-yl]-3,5-difluorophenyl]-5-(1,2-oxazol-3-yloxymethyl)-1,3-oxazolidin-2-one;
CAS Number	252260-02-9 ;
PubChem CID	213049;
ChemSpider	184741 ;
UNII	82V2M8K24R;
CompTox Dashboard (EPA)	DTXSID40870284 DTXSID00948079, DTXSID40870284 ;
ECHA InfoCard	100.234.485
Chemical and physical data
Formula	C21H21F2N3O7
Molar mass	465.410 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O=C1N(CC3=CC(F)=C(C4=CCN(C([C@@H](O)CO)=O)CC4)C(F)=C3)C[C@H](OC2=NOC=C2)O1;
	InChI InChI=1S/C21H21F2N3O7/c22-15-7-13(26-9-14(33-21(26)30)11-31-18-3-6-32-24-18)8-16(23)19(15)12-1-4-25(5-2-12)20(29)17(28)10-27/h1,3,6-8,14,17,27-28H,2,4-5,9-11H2/t14-,17+/m1/s1 ; Key:HBUJYEUPIIJJOS-PBHICJAKSA-N ;
	(what is this?) (verify)

Posizolid is an oxazolidinone antibiotic under investigation by AstraZeneca for the treatment of bacterial infections. At a concentration of 2 mg/L it inhibited 98% of all Gram-positive bacteria tested in vitro.^[1]

References